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A B S T R A C T
Objective: Determine whether (ﬁctitious) health screening test beneﬁts affect perceptions of (unrelated)
barriers, and barriers affect perceptions of beneﬁts.
Methods: UK adults were recruited via an online survey panel and randomised to receive a vignette
describing a hypothetical screening test with either high or low beneﬁts (higher vs. lower mortality
reduction) and high or low barriers (severe vs. mild side-effects; a 2  2 factorial design). ANOVAs
compared mean perceived beneﬁts and barriers scores. Screening ‘intentions’ were compared using
Pearson’s x2 test.
Results: Beneﬁts were rated less favourably when barriers were high (mean: 27.4, standard deviation: 5.3)
than when they were low (M: 28.5, SD: 4.8; p = 0.010, partial h2 = 0.031). Barriers were rated more
negatively when beneﬁts were low (M: 17.1, SD: 7.6) than when they were high (M: 15.7, SD: 7.3; p = 0.023,
partial h2 = 0.024). Most intended to have the test in all conditions (73–81%); except for the low beneﬁt-
high barrier condition (37%; p < 0.0005; N = 218).
Conclusions: Perceptions of test attributes may be inﬂuenced by unrelated characteristics.
Practice implications: Reducing screening test barriers alone may have suboptimal effects on perceptions
of barriers if beneﬁts remain low; increasing screening beneﬁts may not improve perceptions of beneﬁts
if barriers remain high.
ã 2016 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY
license (http://creativecommons.org/licenses/by/4.0/).
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Screening is an important public health strategy for reducing
cancer mortality and incidence. There is potential to improve
population health by increasing uptake of available screening tests
but people’s willingness to undergo them typically requires them
to accept some short-term burden and some level of risk in
exchange for a degree of potential health beneﬁt in the relatively
distant future. Much informative research has been carried out on
how invitees perceive beneﬁts and barriers of screening in order to
address the policy goal of improving uptake (and satisfaction with
screening services in general).
Studies in this area have often been guided by psychological
theories which assume implicitly that perceptions of barriers and
beneﬁts are independent. For example, the Health Belief Model [1]
includes beneﬁts and barriers as discrete ‘constructs’ that are often* Correspondence to: Health Behaviour Research Centre, Department of
Epidemiology & Public Health, UCL, Gower Street, London, WC1E 6BT, UK.
E-mail address: c.wagner@ucl.ac.uk (C. von Wagner).
http://dx.doi.org/10.1016/j.pec.2016.09.007
0738-3991/ã 2016 The Authors. Published by Elsevier Ireland Ltd. This is an open acceanalysed separately (e.g. [2,3]). Similar conceptual and analytical
approaches are also apparent in less theoretically-oriented
research (e.g. where perceived barriers are examined without
assessment of perceived benefts [4]).
However, this assumption may not be not true; appraisals of
barriers may be less negative when beneﬁts are high vs. when they
are low (and likewise for perceptions of beneﬁts when barriers are
low vs. when they are high), even when those beneﬁts are
objectively unrelated. Previous research provides several theoreti-
cal bases for this hypothesis. Most notably, much research has
found evidence that perceptions can be systematically ‘irrational’
in the context of evaluating whether to carry out a given health-
related behaviour. For example, one cognitive shortcut known as
the ‘affect heuristic’ suggests that individuals do not necessarily
carry out separate appraisals of the favourable and unfavourable
characteristics of a behaviour and evaluate the balance. Instead,
both aspects are evaluated together, in the context of a shared
‘pool’ of feeling or emotion (i.e. ‘affect’). That is, where an affective
response towards a behaviour is positive, desirable characteristics
(e.g. health beneﬁts) are judged to be high and aversive character-
istics (e.g. risks or barriers) are judged to be low, whereas thess article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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may also lead to interrelatedness in other ways, such as through
directing attention to particular information: positive feelings
towards screening may increase the extent to which beneﬁts are
focused on and decrease the extent to which barriers are
considered [7]. There are various other rationales for this
hypothesised interaction, some of which are more cognitive in
nature, such as halo effects (in which characteristics of a behaviour
are evaluated in terms of general attitudes towards it) and efforts
to maintain cognitive consistency (i.e. people may attempt to avoid
‘incompatible’ views where favourable aspects of a behaviour are
seen as positive while unfavourable aspects would be seen as
negative simultaneously) [8].
Irrespective of the psychological underpinnings, empirical
evidence provides some support for this hypothesis; cross-
sectional studies have often found that perceptions of screening
test beneﬁts and barriers are negatively correlated [9–12].
However, to our knowledge, no experimental studies have tested
this hypothesis of interrelatedness directly, meaning that their
applicability to screening policy is limited. It is important to
investigate this relationship because efforts to improve screening
uptake based on addressing invitees’ stated barriers will have
limited success if they are proxies for negative perceptions
regarding other aspects of screening.
This study used an experimental design to test whether
modifying test barriers affected perceptions of conceptually
unrelated beneﬁts, and vice versa. Participants were allocated at
random to receive information regarding a screening test with high
or low beneﬁts, and high or low barriers, in the context of a
hypothetical disease with similarities to cancer. Perceived beneﬁts
and barriers were then compared between conditions in order to
test i) whether perceptions of beneﬁts were lower when barriers
were higher, and ii) whether perceptions of barriers were higher
when beneﬁts were lower. Intention to have the hypothetical test
was also compared between conditions as an exploratory analysis
of how the manipulation might affect actual screening behaviour.
2. Materials and methods
2.1. Participants
Recruitment was through Survey Sampling International (SSI,
London, UK), a company which curates a panel of members of the
UK general population who are offered small rewards (such as air
miles) to participate in online surveys. Respondents to the initial
email invitation from SSI were asked their age at the start of the
survey and excluded if they were younger than 25 or older than 75
years (i.e. ineligible for cancer screening in the UK). A software
algorithm applied stratiﬁed sampling to ensure that the sample
resembled the general adult UK population in terms of age; one
third of the sample were aged 25–39 years, one third were aged
40–54 years, and one third were aged 55–75 years.
2.2. Design and measures
2.2.1. Manipulations
This study consisted of a 2  2 between-subjects experimental
design. Participants were invited to complete one of four versions
of a survey, randomly determined by a software algorithm. After
conﬁrming eligibility, they were shown a vignette consisting of
information on the high incidence (33%) of a hypothetical illness
that was amenable to screening (‘Rogan’s disease’), the rationale
for screening, and the extremely high mortality risk in the absence
of a screening test (only 100 in 1000 would survive). Participants
were also given a description of a set of practicalities for a
hypothetical hospital-based screening test, designed to resembleComputed Tomography (a screening test based on x-rays). This test
can include an intravenous dye that carries a small risk of an
adverse reaction, consisting of nausea and vomiting [13], the
severity of which was manipulated as a screening test barrier
(“severe nausea and regular vomiting for 3 days”; “mild nausea and
occasional vomiting for 5 minutes”). The speciﬁc types of beneﬁts
and barriers were selected with the aim of being realistic,
understandable, and plausible to participants, potentially inﬂuen-
tial on their intentions to have the test, as well as being
fundamentally unrelated (as opposed to e.g. false positive and
false negative results).
Information on the degree of beneﬁt was provided in terms of
the mortality risk after undergoing a screening test. This was
manipulated to equal either a large or a comparatively small
reduction in mortality risk (900 per 1000 with Rogan’s disease
who underwent screening would survive; 105 per 1000 would
survive). Fig. 1 contains an example of a complete vignette. Levels
of barriers and beneﬁts were designated “high” and “low” for
convenience.
2.2.2. Comprehension checks
Participants were asked three multiple choice questions with
four response options to assess whether they correctly recalled the
relevant information on mortality risk in the presence or absence
of screening (e.g. “If 1000 people with Rogan’s disease are not
screened and only treated once they feel unwell, how many people will
be successfully treated and survive?”: 100 people; 105 people; 500
people; 900 people), and information on the severity of the
adverse reaction. Responses were coded as either correct or
incorrect based on the allocated condition.
2.2.3. Perceived beneﬁts and barriers scales
Primary outcomes were assessed by seven items measuring
perceived beneﬁts (e.g. “Having the screening test would increase my
chances of surviving Rogan’s disease”) and seven items assessing
perceived barriers of the screening test (e.g. “the side-effects would
be too uncomfortable”). Response options consisted of a ﬁve-point
Likert scale ranging from “strongly disagree” to “strongly agree”.
Items were adapted from existing measures [14–16] and demon-
strated high internal consistency (Cronbach’s a: 0.89 and 0.96,
respectively). Responses were scored from one to ﬁve with higher
scores representing more positive perceptions of beneﬁts and
more negative perceptions of barriers, as applicable. Scores for
individual items were summed to create two overall scale scores
for each participant (each out of 35).
2.2.4. Perceived risk
Participants were asked about perceived risk using an adapta-
tion of a previously designed measure [17] with six response
options (“If I didn’t have the screening test, I think my chances of dying
from Rogan’s disease would be . . . ”: Almost zero; very small;
moderate; large; very large; almost certain).
2.2.5. Self-efﬁcacy
A ﬁve-item assessment of self-efﬁcacy (e.g. “How conﬁdent are
you that...You could ﬁnd the time to have the screening test?”), with
four response options ranging from “very conﬁdent” to “not at all
conﬁdent”, was adapted from a previous measure [18] and this also
had high internal consistency (Cronbach’s a = 0.93). Responses
were scored from one to four; higher scores represented greater
self-efﬁcacy and were summed to create an overall scale score for
each participant (out of 20).
2.2.6. Screening intention
Intention to participate in screening was assessed using an ad-
hoc item: “Imagine the NHS just sent you a letter, inviting you to be
Fig. 1. An example of a complete information vignette (low beneﬁt; high barrier).
A. Ghanouni et al. / Patient Education and Counseling 100 (2017) e1–e24 e3screened for Rogan’s disease. Would you attend the screening test?”).
Response options consisted of “yes”, “no”, and “don’t know”.
2.2.7. Demographics
The survey ended with items assessing demographic character-
istics, including gender, ﬁrst language, and markers of socioeco-
nomic status. A previously used method was used to derive an
overall measure of socioeconomic status, based on responses to
questions on home and vehicle ownership, and education [19]:
One point was counted for living in rented accommodation, no
vehicle ownership, and no formal qualiﬁcations; higher scores
indicated greater deprivation. Previous participation in the three
cancer screening programmes that exist in the UK were also
assessed (cervical, breast and colorectal; questions were tailored
by age and gender so that ineligible participants did not see
irrelevant questions).
At the end of the survey, participants were able to request a
summary copy of the study results. An example of the full survey is
included in Appendix A.1
2.3. Piloting
Prior to data collection, the manipulations for high and low
beneﬁts and barriers were tested in two waves, consisting of 321 Three single items were devised to assess i) perceived barriers, ii) perceived
beneﬁts, and iii) “intention certainty” as part of piloting the survey. These were also
included in the main study but after preliminary analysis of the data, it was unclear
how to interpret the distributions of data. Hence, these ad-hoc items were
considered to lack sufﬁcient face validity and were not used for further analysis
(particularly since superior measures of perceived barriers and beneﬁts were
available).and 26 participants, respectively. Each wave aimed to ensure that
participants in the main study would discriminate between high
and low levels of the two independent variables. In particular, it
was assumed that participants would perceive high beneﬁts from
even very few lives saved through screening, which would have led
to ceiling effects that reduced the perceived differences between
high and low levels. Perceived beneﬁts and barriers of several
possible manipulations were assessed using two ad-hoc items and
results were used to select levels that were likely to generate the
largest possible differences while still being believable to
participants. As an example, the ﬁrst wave of piloting compared
perceived beneﬁts of 800 vs. 200 people surviving following
screening (relative to 100 people surviving without screening).
Notwithstanding the small sample size, scores differed in the
predicted direction but only by a small amount. Consequently, the
second wave of piloting amended the number of lives saved to 900
vs. 105, which was associated with a larger apparent difference in
perceived beneﬁts scores. The ﬁrst wave also compared perceived
barriers of an alternative to test side-effects (travel time to the
hospital: 20 min vs. 2 h). Similar to perceived beneﬁts, scores
differed in the predicted direction but to a smaller degree than the
side-effect manipulation.
The second wave of piloting also assessed performance of the
items adapted from previously used measures of perceived
beneﬁts and barriers, in order to gauge reliability prior to
administering the survey to a larger sample.
2.4. Analysis
Data were analysed using SPSS version 21 for Windows (IBM,
Armonk, NY, USA). Participants answering one or more compre-
hension questions incorrectly were assumed to be insufﬁciently
Fig. 2. Flow of participants through the study.
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Descriptive statistics were used to illustrate frequencies and
proportions for sample characteristics.
Parametric assumptions of data relating to perceived beneﬁts
and barriers (normally distributed residuals and homogeneity of
variance) were tested and met. Hence, the primary analysis
comprised two-way ANOVAs, one in which the dependent variable
consisted of overall perceived beneﬁt score and one in which the
dependent variable was overall barrier score. In each ANOVA,
independent variables consisted of beneﬁt condition (high or low),
barrier condition (high or low) and a beneﬁt  barrier interaction
term. Age-band (25–35, 40–54, and 55–75 years) was included to
account for any effects of stratiﬁed sampling. A sensitivity analysis
was carried out in which the age band variable was omitted; results
did not differ meaningfully and so are not reported here. An
exploratory analysis of screening intentions (proportions intend-
ing to be screened vs. not intending vs. did not know) compared
responses across the four conditions using a Pearson’s x2 test.
Standardised residuals (i.e. z-scores based on the difference
between observed and expected frequencies) were used to test
for differences in proportions between any given pair of conditions.
2.5. Required sample size and hypotheses
The survey was ‘soft-launched’ and recruitment paused after
138 participants had completed the study in order to generate a
preliminary estimate of mean square error for the dependent
variables (necessary to calculate effect size). Since there is a direct
conceptual link between perceptions of beneﬁts and the actual
magnitude of beneﬁts, but not the actual magnitude of barriers, it
was assumed that there would be a larger effect of manipulating
beneﬁts on perceived beneﬁts than that of manipulating barriers.
Likewise, manipulating barriers was expected to have a larger
effect on perceived barriers than manipulating beneﬁts.Calculations were based on a ﬁve-point difference for the effects
of conceptually linked manipulations and a three-point difference
for conceptually unrelated manipulations. Based on the initially
observed mean square errors, it was estimated that a total of 204
participants would be required (51 participants per condition; 80%
power, a = 0.05).
3. Results
3.1. Sample characteristics
The ﬂow of participants through the study is presented in Fig. 2.
After exclusions, 218 participants were included in the main
analysis. Across the whole sample, participants had a mean age of
48.6 years (standard deviation: 13.6), 52.8% were female (n = 115),
86.7% (n = 189) were white British, and 96.3% (n = 210) spoke
English as a ﬁrst language. The majority of screening-eligible
participants reported previous experience of testing, ranging from
73.6% for CRC screening to 87.9% for breast screening. All
demographic and other background characteristics are presented
in Table 1.
3.2. Effects of manipulating barriers (and manipulating beneﬁts) on
perceived beneﬁts
As expected, manipulating beneﬁts had an effect on perceived
beneﬁts, and in the predicted direction (F(1,212) = 55.25, p
< 0.0005), providing an indication that the manipulation was
successful (Mean: 30.0, standard deviation: 4.0 vs. M: 25.6, SD: 5.1
for high vs. low beneﬁts, respectively). The primary hypothesis that
increasing barriers also reduced perceived beneﬁts was also
supported (F(1,212) = 6.81, p = 0.010; M: 28.5, SD: 4.8 vs. M: 27.5,
SD: 5.3 for low vs. high barriers, respectively). As predicted, the
effect of manipulating barriers was smaller (partial h2 = 0.031)
Table 1
Characteristics of analysed participants.
High Beneﬁt
Low barrier
High beneﬁt
High barrier
Low beneﬁt
Low barrier
Low beneﬁt
High barrier
Total
n = 52 (%) n = 64 (%) n = 56 (%) n = 46 (%) n = 218 (%)
Age
Mean (standard deviation) 49.4 (12.6) 47.1 (14.7) 51.2 (12.7) 46.6 (13.8) 48.6 (13.6)
Gender
Male 28 (53.8) 30 (46.9) 27 (48.2) 18 (39.1) 103 (47.2)
Female 24 (46.2) 34 (53.1) 29 (51.8) 28 (60.9) 115 (52.8)
Employment status
Employed 31 (59.6) 38 (59.4) 36 (64.3) 31 (67.4) 136 (62.4)
Not employed/Retired 11 (21.2) 17 (26.6) 19 (33.9) 8 (17.4) 55 (25.2)
Other/Prefer not to say 10 (19.2) 9 (14.1) 1 (1.8) 7 (15.2) 27 (12.4)
Ethnicity
White British 44 (84.6) 55 (85.9) 48 (85.7) 42 (91.3) 189 (86.7)
Other/Prefer not to say 8 (15.4) 9 (14.1) 8 (14.3) 4 (8.7) 29 (13.3)
First language
English 51 (98.1) 61 (95.3) 53 (94.6) 45 (97.8) 210 (96.3)
Other/Prefer not to say 1 (1.9) 3 (4.7) 3 (5.4) 1 (2.2) 8 (3.7)
Socioeconomic status score
0 (Least deprived) 33 (63.5) 32 (50.0) 34 (60.7) 27 (58.7) 126 (57.8)
1 12 (23.1) 24 (37.5) 15 (26.8) 12 (26.1) 63 (28.9)
2 6 (11.5) 7 (10.9) 7 (12.5) 6 (13.0) 26 (11.9)
3 (Most deprived) 1 (1.9) 1 (1.6) 0 (0.0) 1 (2.2) 3 (1.4)
CRC screening experiencea
Yes (75.0) 11 (73.3) 12 (75.0) 7 (70.0) 39 (73.6)
No 3 (25.0) 4 (26.7) 4 (25.0) 3 (30.0) 14 (26.4)
Not sure 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
Not applicable 40 (N/A) 49 (N/A) 40 (N/A) 36 (N/A) 165 (N/A)
Breast cancer screening experience
Yes 12 (85.7) 13 (100.0) 13 (72.2) 13 (100.0) 51 (87.9)
No 2 (14.3) 0 (0.0) 5 (27.8) 0 (0.0) 7 (12.1)
Not sure 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
Not applicable 38 (N/A) 51 (N/A) 38 (N/A) 33 (N/A) 160 (N/A)
Cervical cancer screening experience
Yes 23 (95.8) 28 (82.4) 28 (96.6) 20 (71.4) 99 (86.1)
No 1 (4.2) 6 (17.6) 1 (3.4) 7 (25.0) 15 (13.0)
Not sure 0 (0.0) 0 (0.0) 0 (0.0) 1 (3.6) 1 (0.9)
Not applicable 28 (N/A) 30 (N/A) 27 (N/A) 18 (N/A) 103 (N/A)
Perceived chance of dying of Rogan’s
disease (in the absence of screening)
Almost zero 0 (0.0) 0 (0.0) 2 (3.6) 3 (6.5) 5 (2.3)
Very small 7 (13.5) 10 (15.6) 18 (32.1) 17 (37.0) 52 (23.9)
Moderate 16 (30.8) 25 (39.1) 16 (28.6) 14 (30.4) 71 (32.6)
Large 16 (30.8) 11 (17.2) 10 (17.9) 8 (17.4) 45 (20.6)
Very large 12 (23.1) 12 (18.8) 7 (12.5) 3 (6.5) 34 (15.6)
Almost certain 1 (1.9) 6 (9.4) 3 (5.4) 1 (2.2) 11 (5.0)
Self-efﬁcacy
Mean (standard deviation) 7.8 (3.2) 8.6 (2.9) 8.7 (3.0) 11.0 (3.6) 8.9 (3.3)
a Screening experience percentages are for age- and gender-applicable subgroups.
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the effects of the interaction term, there was only weak evidence
against the null hypothesis (p = 0.137).
3.3. Effects of manipulating beneﬁts (and manipulating barriers) on
perceived barriers
The manipulation of barriers was also successful; perceived
barrier scores were higher when barriers were high (F
(1,212) = 51.03, p < 0.0005; M: 19.6, SD: 7.6 vs. M:13.1, SD: 5.7).
Consistent with the main hypothesis, increasing beneﬁts also
reduced perceived barriers (F(1,212) = 5.23, p = 0.023; M: 17.1, SD:7.6 vs. M: 15.7, SD: 7.3 for low vs. high beneﬁts, respectively). Again,
this effect was smaller (partial h2 = 0.024) than that of manipulated
barriers (partial h2 = 0.194). There was weak evidence against the
null hypothesis with respect to the effects of the interaction term
(p = 0.159). Table 2 reports means and standard deviations for
perceived beneﬁt and barrier scores for each of the four conditions.
3.4. Screening intentions
There was strong evidence against the null hypothesis of equal
proportions of intention categories across conditions
(x2(6) = 43.26, p < 0.0005). Follow-up analyses of standardised
Table 2
Crude means and standard deviations for perceived beneﬁt and barrier scores for all
four conditions.
Possible combinations of beneﬁts and barriers levels
High beneﬁts
Low barriers
High beneﬁts
High barriers
Low beneﬁts
Low barriers
Low beneﬁts
High barriers
(n = 52) (n = 64) (n = 56) (n = 46)
Perceived beneﬁts 30.4 (4.3) 29.7 (3.8) 26.7 (4.7) 24.2 (5.4)
Perceived barriers 12.6 (6.0) 18.2 (7.3) 13.5 (5.4) 21.5 (7.7)
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ipants did not intend to be screened in the low beneﬁt-high barrier
condition, (34.8% vs. 0.0%–7.1%; z =  2.5; p < 0.05), and a smaller
proportion did intend to be screened (37.0% vs. 73.2%–80.8% z = 5.1;
p < 0.01). In addition, fewer participants did not intend to be
screened in the high beneﬁt-low barrier condition (0.0% vs.
4.7%–34.8%; z =  2.3; p < 0.05). Proportions of participants
responding with “don’t know” were comparable between all
conditions (19.2%–21.9%; Fig. 3).
4. Discussion and conclusion
4.1. Discussion
These ﬁndings provide evidence that screening attributes are
not appraised independently but jointly, and manipulating one
affects evaluations of the other. Our results build on cross-sectional
studies that have demonstrated a negative correlation between
beneﬁts and barriers of cancer screening tests [9–12] by showing
that to some extent these correlations are likely to be due to a
degree of interrelatedness between the two characteristics. This
study also found that the large majority of participants stated that
they would have the test in three of the four conditions. However,
there was a marked difference in the worst condition (low beneﬁts,
high barriers), with a greater proportion stating that they would
not have the test. This exploratory analysis offers some indication
that barriers and beneﬁts might interact in a way that inﬂuences
screening uptake. Further research would also be necessary to
understand how intentions (and ultimately actual uptake) relate to
the observed interaction.
Although there is evidence that barriers and beneﬁts are good
predictors of behaviour when assessed individually [1,20], there
has been extensive criticism of the assumption made by the Health
Belief Model that they have simple additive effects [1,21]. In this
respect, the present ﬁndings support researchers’ recommenda-
tions for alternative approaches that examine moderation among
variables [1]. Our results further suggest that a degree of caution is
warranted regarding research that aims to identify speciﬁc barriers
to cancer screening without simultaneously addressingFig. 3. Proportions of screening intention responses across each condition.perceptions of beneﬁts [4]: The issues that participants raise as
important barriers to screening may be proxies for being
unconvinced about the beneﬁts [22,23]. One further implication
of these results is that screening tests with greater barriers might
also elicit less positive perceptions of beneﬁts. For example,
ﬂexible sigmoidoscopy screening for colorectal cancer (CRC)
involves an invasive, internal examination and an inconvenient
bowel preparation, which might diminish the effectiveness of
interventions to improve uptake that aim solely to communicate
its efﬁcacy in terms of reducing CRC incidence and mortality.
Conversely, these ﬁndings suggest that there may be potential to
improve perceptions of screening test beneﬁts by reducing barriers
(and vice versa). As a practical example, as the Bowel Cancer
Screening Programme in England replaces one method of stool
testing with a less inconvenient alternative [24], this reduced
inconvenience may lead to more favourable appraisals of the test’s
capability to reduce mortality.
This study has limitations. The context of screening for a
hypothetical illness allowed beneﬁts and barriers to be manipu-
lated freely, to the point that participants could discriminate
between the two levels of each independent variable. However, the
implications for practice with respect to real screening contexts are
undetermined. It is notable that pilot work found similar beneﬁt
scores for even large differences in mortality reduction. The small
observed effects may not apply to real screening contexts in which
differences between tests are subtler. In addition, participants
were excluded if they answered one of the three ‘comprehension
check’ questions incorrectly, despite assistance offered to help
them respond correctly. This approach aimed to exclude partic-
ipants from the analysis if they had not read the relevant
information and so were not sufﬁciently engaged with the study.
However, it might have also resulted in a sample that was more
numerate or literate than the general population. The proportion of
exclusions was also greater in the low beneﬁt-high barrier
condition.
This study tested whether barriers affected perceptions of
beneﬁts and vice versa. However, it did not aim to test whether any
particular psychological mechanism underpinned this relation-
ship. The ﬁndings are consistent with the presence of an affect
heuristic [5], which has been used to explain similar effects in
appraisals of other technologies [6], but it is also consistent with
various alternative explanations such as directing attention
towards particular kinds of information [7], a halo effect, and
attempts to avoid cognitive dissonance [8]. Further studies would
be necessary to explore these possibilities. For example, subse-
quent studies could use a similar design but include measures of
emotion in order to test for affective explanations. In the ﬁrst
instance, it would be important to test whether the effects of
absolute barriers and beneﬁts on unrelated outcomes were
mediated via perceived barriers and beneﬁts, respectively. Further
research that uses these approaches would make a greater
contribution to psychological theory.
Other areas for further research relate to the speciﬁc
manipulations used: The set of beneﬁts and barriers manipulated
in the present study were selected following pilot work that aimed
to maximise the chances of observing the hypothesised effect
while still being believable to participants. This effect may not
necessarily have been apparent with other beneﬁts or barriers (e.g.
one of our original tested barriers of travel distance to the hospital,
which appeared to elicit smaller differences in perceived barriers
between longer and shorter journey times than in the case of the
side-effects attribute). However, characteristics of real screening
tests are complex and multifactorial. Beneﬁts can be medical and
psychological; barriers can also be psychological as well as
practical [21]. It may be particularly valuable to policy makers
to determine the effects of manipulating speciﬁc characteristics of
A. Ghanouni et al. / Patient Education and Counseling 100 (2017) e1–e24 e7screening tests. For example, the risk of overdiagnosis in the case of
breast cancer screening is the subject of intense debate [25] since it
results in unnecessary treatment and the psychological harms of a
cancer diagnosis. Overdiagnosis may be perceived more negatively
by screening invitees than the practical barriers described in this
study. Furthermore, it is often unfeasible to change real character-
istics of screening tests but it is much easier to alter information
in screening invitations. For example, different degrees of emphasis
can be placed on information about barriers or beneﬁts (e.g. by
giving them greater prominence within an invitation leaﬂet, or
by reiterating them in a leaﬂet summary). Manipulating these
characteristicsmay increaseordecrease someof the effects observed
here. Moreover, the results of this study suggest that manipulating
both attributes would have more than just an additive effect.
4.2. Conclusion
We found evidence that manipulating barriers of a screening
test inﬂuenced perceived beneﬁts and that manipulating beneﬁts
inﬂuenced perceived barriers. Future research should test the
possible underlying psychological mechanisms and investigate the
extent to which these ﬁndings generalise to real screening
contexts. This would inform policy makers in their efforts to
improve the balance of screening barriers and beneﬁts in order to
increase uptake.
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